![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2021
Anzahl der Publikationen: 2
2021
Bickert, Christiane 
ORCID: https://orcid.org/0000-0003-4121-6687; Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Götschke, Jeremias ORCID: https://orcid.org/0000-0002-3426-2194; Syunyaeva, Zulfiya; Behr, Jürgen und Tufman, Amanda
(2021):
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211018028: S. 1-7
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-4121-6687; Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Götschke, Jeremias ORCID: https://orcid.org/0000-0002-3426-2194; Syunyaeva, Zulfiya; Behr, Jürgen und Tufman, Amanda
(2021):
Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211018028: S. 1-7
[PDF, 2MB]
Kahnert, Kathrin ORCID: https://orcid.org/0000-0001-9633-3368; Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117; Lucke, Tanja; Trudzinski, Franziska C.; Mertsch, Pontus; Bickert, Christiane; Ficker, Joachim H.; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Bals, Robert; Watz, Henrik; Welte, Tobias; Vogelmeier, Claus F. und Alter, Peter
(2021):
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET.
In: International Journal of Chronic Obstructive Pulmonary Disease, Bd. 16: S. 3189-3199
ORCID: https://orcid.org/0000-0001-9633-3368; Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117; Lucke, Tanja; Trudzinski, Franziska C.; Mertsch, Pontus; Bickert, Christiane; Ficker, Joachim H.; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Bals, Robert; Watz, Henrik; Welte, Tobias; Vogelmeier, Claus F. und Alter, Peter
(2021):
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET.
In: International Journal of Chronic Obstructive Pulmonary Disease, Bd. 16: S. 3189-3199